期刊档案 · Medicine-Endocrinology, Diabetes and Metabolism

Discover Oncology

ISSN 2730-6011 · Springer Nature · Switzerland

Discover Oncology 中科院 医学 4区(2025 年升级版),影响因子 2.78,完全开放获取,APC 约 2,390 美元,近 24 个月 195 篇文章投稿到接收中位 130 天,2025 年发文 2,542 篇,SCIE、Scopus 收录。

影响因子2.78LetPub 汇总的最新公布值
中科院分区医学 4区2025 年升级版大类 · 2026 新锐版 医学 3区
审稿周期130 天投稿到接收中位数 · 近 24 个月 195 篇文章 · Crossref
版面费2,390 USD完全开放获取
录用比例—暂无反馈
年发文量2,542 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Discover Oncology 由 Springer Nature 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Ferroptosis and cancer prognosis、Cancer Immunotherapy and Biomarkers、Cancer-related molecular mechanisms research 等主题的论文,这 3 个主题约占 39.1%,主导子领域为 Cancer Research。(根据 OpenAlex 主题统计与中科院分区数据生成)

• 欢迎从与肿瘤学相关的各个领域发表的研究论文 • Discover系列期刊,专注于快速的稿件提交和评审过程,提供优质服务保障科研诚信 • 开放获取(OA) 扩大研究全球影响 Discover 是 Springer Nature 旗下的开放获取期刊品牌, 面向广泛科研群体, 支持研究人员以开放方式发表并分享研究成果。Discover 覆盖应用科学、物理科学、生命科学、医学及社会科学等领域, 强调包容性、高效发表与研究成果的有效传播, 助力科研发现转化为可被看见和使用的学术贡献。

Discover Oncology is part of the Discover journal series committed to providing a streamlined submission process, rapid review and publication, and a high level of author service at every stage. Discover Oncology is a fully open access general oncology journal that aims to provide a unified forum for researchers and clinicians. The journal spans from basic and translational science, through to preclinical, clinical, and epidemiology, and welcomes content that interfaces at all levels of cancer research. Topics Discover Oncology covers topics including, but not limited to, cancer causation and the underlying biology of disease, the molecular interactions between genes, hormones, the immune system and the metabolism, screening and prevention, diagnosis and treatment, prognostication, novel therapeutic agents and clinical trials. All cancer types, including benign tumors, will be considered for publication. Content Types Discover Oncology welcomes a variety of article types – please see our submission guidelines for details. The journal also publishes guest-edited Topical Collections of relevance to all aspects of cancer research to allow readers to quickly identify research on subject areas of especial interest to them. For more information, please follow up with our journal publishing contact. In addition to specific themed Collections reflecting the latest developments in cancer research, the journal focuses on three types of contributions: forward looking and/or speculative pieces that may be opinionated but should remain balanced and are intended to stimulate discussion and explore new approaches, rapid publication of early research results, and case studies/examples of novel research.

摘自期刊官网 Aims & Scope

研究方向(LetPub):Medicine-Endocrinology, Diabetes and Metabolism

主编 Eleonora Candi出版商官网

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Ferroptosis and cancer prognosisMedicine22.6%
  2. Cancer Immunotherapy and BiomarkersMedicine10.7%
  3. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.9%
  4. Immune cells in cancerImmunology and Microbiology4.7%
  5. Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.5%
  6. RNA modifications and cancerBiochemistry, Genetics and Molecular Biology4.4%
  7. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.4%
  8. Single-cell and spatial transcriptomicsBiochemistry, Genetics and Molecular Biology4.3%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类内分泌学与代谢ENDOCRINOLOGY & METABOLISM4 区
小类肿瘤学ONCOLOGY4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 3 区
类别学科分区
大类医学3 区
小类肿瘤学ONCOLOGY3 区
小类内分泌学与代谢ENDOCRINOLOGY & METABOLISM4 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 4 区
类别学科分区
大类医学4 区
小类内分泌学与代谢ENDOCRINOLOGY & METABOLISM4 区
小类肿瘤学ONCOLOGY4 区

Top 期刊:否综述期刊:否

数据库收录

SCIEScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

EmbaseCAS出版商官网

其他:Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子
2.78LetPub ·
影响因子(出版商公布) 2025
2.8出版商官网 ·
五年影响因子(出版商公布) 2025
2.9出版商官网 ·
CiteScore 2026-06
1.9LetPub ·
SJR 2026-06
0.73LetPub ·
SNIP 2026-06
0.54LetPub ·
h-index
35OpenAlex ·
i10-index
452OpenAlex ·
两年平均被引
2.39OpenAlex ·
自引率
7.1%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
2,517LetPub ·
年下载量(出版商公布) 2025
4,300,000出版商官网 ·

逐年发文量 OpenAlex 统计 · 累计 5,442 篇 · 当年数据不完整

年份发文量其中 OA被引
20261,6041,604349
20252,5422,5427,153
20248498494,415
20232362362,442
20221461461,937
202165651,122

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 Crossref 登记的稿件日期 · 至

130 天投稿到接收中位数 · P25–P75 98 天 – 161 天

接收到上线
中位数 11 天(195 篇)
投稿到上线
中位数 143 天
样本
195 篇有投稿与接收日期的文章(窗口内共 4,468 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
5 WeeksLetPub ·
投稿到首次决定
19 天出版商官网 ·
投稿到发表(期刊自报)
约 5 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJEUR 1,990 / USD 2,390 / GBP 1,690有CC BY、CC BY-NC-ND
OpenAlexUSD 1,690 / EUR 1,240 / GBP 1,140——
LetPubGBP 1,090 / USD 1,590 / EUR 1,190有—

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

征稿中的专刊3 个,按截稿日期
  1. Advances in Targeted Therapy for Breast Cancer: Pathway to Personalized Cancer Care - Volume II截稿
  2. Chronic Inflammatory Skin Diseases and Cancer: Risk, Immunity, and Therapeutic Crossroads截稿
  3. Innate T Cells in Cancer: Biology, Immunotherapy, and Translational Advances截稿
出版商官网
投稿准备要点3 项,摘自作者指南
摘要
≤ 250 词
参考文献格式
顺序编码制(按引用顺序编号)
投稿信(Cover letter)
必须提供
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型14 种
  1. analysisAnalysis papers present an analysis of existing data, or new data obtained through comparative analysis of technologies, methods or reagents of relevance to the…未说明篇幅
  2. brief reportWhen you first submit in SNAPP you will need to choose the correct article type.This journal accepts the following article types: Research Research articles pre…未说明篇幅
  3. case reportWhen you first submit in SNAPP you will need to choose the correct article type.This journal accepts the following article types: Research Research articles pre…未说明篇幅
  4. case studyCase Studies report specific instances of interesting phenomena, providing relevant material to support both research and education through the transferability …未说明篇幅
  5. clinical trialDiscover journals adopt WHO’s definition of Clinical Trials as “any research study that prospectively assigns human participants or groups of humans to one or m…未说明篇幅
  6. commentComment articles can focus on policy, science and society, or purely scientific issues.未说明篇幅
  7. data noteData Notes concisely describe sound research data with the aim of increasing visibility and transparency, supporting the reuse of research data and helping auth…未说明篇幅
  8. editorialWhen you first submit in SNAPP you will need to choose the correct article type.This journal accepts the following article types: Research Research articles pre…未说明篇幅
  9. full research articleWhen you first submit in SNAPP you will need to choose the correct article type.This journal accepts the following article types: Research Research articles pre…未说明篇幅
  10. matters arisingMatters Arising articles are interesting and timely scientific or academic comments and clarifications on original research papers published in the journal.未说明篇幅
  11. researchResearch articles present new scientific results within the scope of the journal that have not been published previously and are not being considered for public…未说明篇幅
  12. research articleWhen you first submit in SNAPP you will need to choose the correct article type.This journal accepts the following article types: Research Research articles pre…未说明篇幅
  13. research paperWhen you first submit in SNAPP you will need to choose the correct article type.This journal accepts the following article types: Research Research articles pre…未说明篇幅
  14. reviewReview articles provide critical accounts and comprehensive surveys of topics of major current interest within the scope of the journal.未说明篇幅
出版商官网
官网政策摘录作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审
作者资格

该期刊要求所有作者因其贡献获得署名并对其负责,且需说明各作者对稿件的具体贡献。 模型中文摘要

All authors should be credited for their contributions, and be accountable for them. You will need to specify how authors contributed to the manuscript.

原文 ↗出版商官网 ·
利益冲突

作者必须声明与所述工作相关的任何竞争性财务和/或非财务利益。 模型中文摘要

Authors are required to declare any competing financial and/or non-financial interests in relation to the work described.

原文 ↗出版商官网 ·
数据可用性

所有作者在投稿时必须包含数据可用性声明。 模型中文摘要

All authors must include a data availability statement in their submission.

原文 ↗出版商官网 ·
出版伦理

如工作涉及人类或动物受试者、其数据和/或生物材料,则需提供伦理声明。 模型中文摘要

Ethics statement - if requiredYou will need to include an ethics declaration if your work reports research involving human or animal subjects, their data and/or biological materials.

原文 ↗出版商官网 ·
许可与版权 Step 4 - Understand your copyright

稿件被接受后,作者须与施普林格·自然签署许可协议:作者保留文章版权,授予施普林格·自然出版许可,保留完整再利用权利,文章将以知识共享许可发布供第三方部分再利用。 模型中文摘要

If your submission is accepted for publication, you will need to sign a licence agreement with Springer Nature to allow us to publish your article. According to this agreement:authors of articles published in this journal retain the copyright of their articles.authors grant Springer Nature a licence to publish the article and identify itself as the original publisher.authors retain full re-use rig…

原文 ↗出版商官网 ·
开放获取 Open access publishing

有关在Discover Oncology开放获取发表的费用、资助和许可信息,请访问期刊的开放获取出版页面。 模型中文摘要

To find out more about publishing your work Open Access in Discover Oncology, including information on fees, funding and licences, visit our Open access publishing page. Back to top Did you find what you were looking for? Share feedback.

原文 ↗出版商官网 ·
同行评审 Step 3 - Understand the peer review policy

该期刊采用单盲同行评审:审稿人知晓作者姓名和单位,但提供给作者的审稿报告是匿名的。 模型中文摘要

This journal follows a single-anonymous peer review procedure, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Peer review process All manuscripts undergo technical checks upon submission. Manuscripts that pass technical checks undergo suitability checks by our in-house editorial team. Eligible manuscripts are …

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Springer Nature
出版国家或地区
Switzerland
出版语言
English
ISSN
2730-6011
官方链接

常见问题

关于 Discover Oncology 的常见问题

Discover Oncology 是中科院几区期刊?

2025 年升级版分区表中,Discover Oncology 为医学 4区,小类 内分泌学与代谢 / 肿瘤学 4 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。

Discover Oncology 的影响因子是多少?

LetPub 汇总的最新公布影响因子为 2.78,CiteScore 为 1.9,h-index 为 35。

Discover Oncology 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)195 篇已发表文章登记的日期,投稿到接收的中位数为 130 天(四分位 98–161 天);投稿社区反馈的平均审稿速度为约 5 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Discover Oncology 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 250 词;参考文献格式:顺序编码制(按引用顺序编号);投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Discover Oncology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Discover Oncology 被 SCIE、Scopus、DOAJ 收录。期刊官网自述还被 Embase、CAS 收录,该清单未与各数据库逐一核对。

Discover Oncology 是开放获取期刊吗?版面费多少?

Discover Oncology 为完全开放获取。APC 约 2,390 美元。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。